氯沙坦钾对白大衣高血压患者100例临床观察(2)
 |
| 第1页 |
参见附件。
[8] Chobanian AV，Bakris GL，Black HR.The seventh report of the joint national committee on prevention，detection，evaluation，and treatment of high blood pressure.JAMA. 2003. 289：2560
[9] Tsazuki S，Matoba T，Eyuchis，et a1.Angiotensin II type 2 receptor inhibits cell proliferation and activated tyrosine phosphatase [J].Hypertension，1996，28：916
[10] Pierdomenico SD，Costantini F，Bucci A，et al.Low-density lipe protein oxidation and vitamins E and C in sustained and white-coat hypertension l J].Hypertension，1998，31(2)：621-626
[11] Sjorklund K，Lind L.Vessby B，et al.Diferent metabolic predictors of whitecoat and sustained hypertension over a 20-year follow- p pe riod：a population-based study of elderlymen [J].Circulation，2002，106(1)：63-68
[12] Flores L.Recasens M，Gomis R，et a1.Wh coat hypertension in type 1 diabetic patients without nephropathy[J].Am J Hypertens，2000，13(5 Pt 1)：560-563
[13] Ribeiro L.Gam a G，Santos A，et a1.Arterial distensibility in subjects with white-coat hypertension with an d without diabetes or dyslipidaemia：comparison with normotensives and sustained hypertensives[J].Blood Press Monit，2000
[14] Moreira.Alcantara P，Aleantara C，et a1.Cardiac structure and functional alterations in white coat hypertension[J].Am J Hypertens，2003，16(5)：172
[15] 朱雅萍,方宁远[J]. 中华老年多器官疾病杂志2005年3月第4卷第1期.Chin J Mult Organ Dis Elderly Mar 2005 Vol 4 No 1:59-6
[16] 赵宇程，陆备军等[J].《心血管病防治知识》杂志,2011年1月第一期，下半月
您现在查看是摘要介绍页，详见PDF附件(1364kb)。